Human herpesvirus 6
Human herpesvirus 6 (HHV-6) is a set of two closely related herpesviruses, HHV6-A and HHV6-B. Infection is extremely common and usually occurs at an early age. 64-83% of infants are infected by age 13 months. HHV-6 has an affinity for leukocytes and nervous tissue, especially the olfactory bulb tissues, from which it is thought to disseminate to other parts of the brain. After infection the virus remains latent but can reactivate asymptomatically even in healthy individuals.
In human disease[edit | edit source]
Multiple sclerosis[edit | edit source]
Antivirals may have some therapeutic benefit. A randomized, placebo-controlled double-blind study found that acyclovir reduced the exacerbation rate in relapsing-remitting MS patients.. Valacyclovir reduced new lesions in patients with high disease activity.
Cancer[edit | edit source]
Chronic fatigue syndrome[edit | edit source]
One study found a higher prevalence of past HHV-6 infection in chronic fatigue syndrome patients but with a low viral load that did not suggest reactivation. Several studies have found that active infection is more common in CFS patients than healthy controls.
[edit | edit source]
Notable studies[edit | edit source]
- 1994, Prevalence of Human Herpesvirus 6 Variants A and B in Patients with Chronic Fatigue Syndrome
- 2016, Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue
Learn more[edit | edit source]
- HHV-6 Foundation
- 2018, A Common Virus May Play Role in Alzheimer’s Disease, Study Finds by Pam Belluck via NY Times
See also[edit | edit source]
References[edit | edit source]
- Pietiläinen-Nicklén J, Virtanen JO, Uotila L, Salonen O, Färkkilä M, Koskiniemi M. (2014). HHV-6-positivity in diseases with demyelination. Journal of Clinical Virology, 61 (2):216-9. doi: 10.1016/j.jcv.2014.07.006. Epub 2014 Jul 21. Rerieved from http://www.ncbi.nlm.nih.gov/pubmed/25088617
- Aoki, R; Kobayashi, N; Suzuki, G; Kuratsune, H; Shimada, K; Oka, N; Takahashi, M; Yamadera, W; Iwashita, M; Tokuno, S; Nibuya, M; Tanichi, M; Mukai, Y; Mitani, K; Kondo, K; Ito, H; Nakayama, K (2016), "Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue", Biochemical and Biophysical Research Communications, 478 (1): 424-30, doi:10.1016/j.bbrc.2016.07.010, PMID 27396623
chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.